Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges.
about
Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalisPredominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic ReviewCurrent progress with Moraxella catarrhalis antigens as vaccine candidatesComprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance modelAntibodies to the HMW1/HMW2 and Hia adhesins of nontypeable haemophilus influenzae mediate broad-based opsonophagocytic killing of homologous and heterologous strains.Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling.Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2.Construction of a mutant and characterization of the role of the vaccine antigen P6 in outer membrane integrity of nontypeable Haemophilus influenzae.Moraxella catarrhalis is susceptible to antimicrobial photodynamic therapy with Photofrin.Innate immunity and the role of defensins in otitis media.The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program.Vaccine targets against Moraxella catarrhalis.Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infectionGalactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination.Dual orientation of the outer membrane lipoprotein P6 of nontypeable haemophilus influenzae.Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.Mouse models for the study of mucosal vaccination against otitis media.Current progress of adhesins as vaccine candidates for Moraxella catarrhalis.Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.Naturally Acquired HMW1- and HMW2-Specific Serum Antibodies in Adults and Children Mediate Opsonophagocytic Killing of Nontypeable Haemophilus influenzae.Trends in the epidemiology of invasive Haemophilus influenzae disease in Queensland, Australia from 2000 to 2013: what is the impact of an increase in invasive non-typable H. influenzae (NTHi)?Moraxella catarrhalis binding to host cellular receptors is mediated by sequence-specific determinants not conserved among all UspA1 protein variants.Mucosal immunization with the Moraxella Catarrhalis porin m35 induces enhanced bacterial clearance from the lung: a possible role for opsonophagocytosis.Vaccine candidate P6 of nontypable Haemophilus influenzae is not a transmembrane protein based on protein structural analysisInvestigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera.Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation.Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008.Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae
P2860
Q24684942-C960D4B4-15F1-4088-8C8B-6FC1EC042DBBQ26767290-02AE87A6-67E6-4506-9BA1-2683158D5A10Q28304447-EA1A77E5-0A52-40E6-99DB-E590CEC1778CQ28382833-C9359EFE-6262-4C2C-9819-C8D613D2ADC5Q33601848-BCB6CFFD-4342-4309-A676-F4430BFB7845Q33911347-8493DD47-9A66-4481-A11A-39DB65DEC1B8Q34778118-AFA087F4-4658-42FF-9D45-68A84F7FC11DQ35073764-0B09643C-E24F-4182-BAEE-2A459AD755C4Q35231187-FFA3D3BE-048F-4DEA-AC54-59D9D44EDD06Q35529089-F3938C91-F09D-45DB-8920-9CFC901C76FDQ35887754-AC8CF006-9BD8-43D5-8B06-F80BB109DAB9Q36483998-E80E7952-0C60-4EC1-9198-F322699C4E8CQ36539535-3F1C4259-932E-40F0-B656-B74625060398Q36845123-7B28997A-496F-4C59-B8BF-D5DE49366EE5Q36970929-8B5F2A42-D374-4F33-941D-100698C9408AQ36976255-E5DEDAE1-0009-4993-8017-469B31CA38DDQ37093093-87247DE6-BC96-4EA4-98F8-3EABD2057850Q37123450-94DB4252-4252-40B1-8A72-05F9E5F35EF5Q37441243-93AF6522-A3F7-4EC5-BFA1-50163A178461Q40289378-3823C0AB-9D36-4794-8D98-CB2501DDE06FQ40933342-D80D1BDA-7310-4D73-AF80-BD63080A9CD7Q41242217-7A29B2C4-82E3-42ED-A3D0-C5C874A91A06Q42119476-12037DFF-1798-4C50-89A2-584BF51BEFE0Q42143952-823B07D0-2650-4D34-99AC-40ABD8F4E651Q42250209-889C1C11-6B84-4F0E-B149-83A0D12CB2C1Q42601451-77F0990E-B3FD-4FF4-91FF-5AB9C77F085DQ42909736-5FF7FBC6-0025-4109-9107-CD6EACADB848Q51172830-B6B8E498-4AD8-42CB-B5E5-62AA2755BD04Q58101270-6F9BF6DC-ABDD-4DEC-963E-C4CE1D939E15
P2860
Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Vaccine development for non-ty ...... alis: progress and challenges.
@ast
Vaccine development for non-ty ...... alis: progress and challenges.
@en
type
label
Vaccine development for non-ty ...... alis: progress and challenges.
@ast
Vaccine development for non-ty ...... alis: progress and challenges.
@en
prefLabel
Vaccine development for non-ty ...... alis: progress and challenges.
@ast
Vaccine development for non-ty ...... alis: progress and challenges.
@en
P2860
P356
P1476
Vaccine development for non-ty ...... alis: progress and challenges.
@en
P2860
P304
P356
10.1586/14760584.4.6.843
P577
2005-12-01T00:00:00Z